LA
MBII

Latitude Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Latitude Advisors’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,690
Closed -$17K – 336
2022
Q1 		$17K Buy
15,690
+5,230
+50% +$3.95K ﹤0.01% 329
2021
Q4 		$8K Hold
10,460
– – ﹤0.01% 301
2021
Q3 		$9K Buy
+10,460
New +$12.6K ﹤0.01% 283

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Latitude Advisors's MBII Position: Q2 2022 in Review

Latitude Advisors sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 15,690 shares — an estimated $17K sold.

Latitude Advisors first reported a position in MBII in Q3 2021 and held it in 3 quarters. The position peaked at $17K in Q1 2022. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Latitude Advisors reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Latitude Advisors sold 15,690 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $17K.
  • Latitude Advisors first reported a position in Marrone Bio Innovations, Inc. in Q3 2021 and held it in 3 quarters.
  • Latitude Advisors's Marrone Bio Innovations, Inc. position peaked at $17K in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Latitude Advisors's 13F filing for Q2 2022, filed 28 Jul 2022.